Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 3, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$167B
sum of reported positions
Reported positions
567
Changes vs prior quarter
589
80 new · 75 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 178 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $145B | $167B |
| Positions | 562 | 567 |
| Biggest line | — | NVIDIA 8% |
| 21.4M |
| $8.09B |
| 4.8% |
| 18.8M | $6.72B | 4.0% |
| 5.46M | $6.55B | 3.9% |
| 16.3M | $6.09B | 3.7% |
| 9.97M | $5.79B | 3.5% |
| 10.7M | $5.1B | 3.1% |
| 14M | $4.95B | 3.0% |
| 7.37M | $4.15B | 2.5% |
| 10.9M | $4.08B | 2.4% |
| 8.57M | $3.6B | 2.2% |
| 3.76M | $2.87B | 1.7% |
| 5M | $2.57B | 1.5% |
| 6.93M | $2.38B | 1.4% |
| 18.5M | $2.1B | 1.3% |
| 9.52M | $2.06B | 1.2% |
| 2.17M | $2.03B | 1.2% |
| 27.1M | $1.93B | 1.2% |
| 6.86M | $1.79B | 1.1% |
| 4.5M | $1.69B | 1.0% |
| 9.22M | $1.63B | 1.0% |
| 6.34M | $1.61B | 1.0% |
| 3.53M | $1.53B | 0.9% |
Morgan Stanley (MS)
2,305 shares
Primoris Services Corporation (PRIM)
8,148 → 4,607 shares (−44%)
Planet Labs Pbc (PL)
17K → 13K shares (−23%)
Chewy (CHWY)
787K → 21K shares (−97%)
Oklo (OKLO)
7,813 shares
VANGUARD INTL EQUITY INDEX F
8,802 → 2,517 shares (−71%)
STATE STR SPDR S&P MIDCAP 40
1,874 → 561 shares (−70%)
Plug Power (PLUG)
145K shares
ISHARES TR
2,342 → 1,971 shares (−16%)
Marriott International (MAR)
755 → 729 shares (−3%)
ISHARES TR
2,355 shares
Marvell Technology (MRVL)
781 shares
ISHARES TR
4,755 → 2,095 shares (−56%)
Infleqtion (INFQ)
14K shares
Olema Pharmaceuticals (OLMA)
1.82M shares in Q1 2026
Dow Inc. (DOW)
1.39M shares in Q1 2026
Xp (XP)
1.36M shares in Q1 2026
DUPONT DE NEMOURS INC
1.32M shares in Q1 2026
Gilead Sciences (GILD)
1.26M shares in Q1 2026
Option Care Health (OPCH)
1.21M shares in Q1 2026
Dentsply Sirona (XRAY)
1.07M shares in Q1 2026
Dexcom (DXCM)
1.05M shares in Q1 2026
GREAT LAKES DREDGE & DOCK CO
1.03M shares in Q1 2026
Vertex (VERX)
982K shares in Q1 2026
Umh Properties (UMH)
933K shares in Q1 2026